The brain is one of the most energetically demanding organs within the human body and is cognitively susceptible to energetic deficits such that the rise in obesity, insulin resistance, and Alzheimer’s disease in recent decades pose a substantial threat to cognitive longevity. The therapeutic efficacy of ketones are well-established in epilepsy and are currently being applied to other disease states. Alzheimer’s disease is characterized by impairments in brain glucose uptake and metabolism in regions relevant to learning, memory, and cognition that progress with the disease. While brain glucose uptake is impaired, ketone uptake is unaltered, potentially enabling ketones to fuel the glucose-deficient brain. Using RNA-seq data acquired from multiple publicly available AD databases, we assessed glycolytic and ketolytic gene expression in post-mortem AD and cognitively normal control brains. Gene expression was normalized to brain region – parietal lobe, cerebellum, temporal cortex, frontal lobe, inferior frontal gyrus, parahippocampal gyrus, superior temporal gyrus – and cell type – neurons, astrocytes, oligodendrocytes, and microglia. We report impairments in glycolytic gene expression in regions of the brain relevant to memory and cognition in neurons and oligodendrocytes, but not ketolytic gene expression in neurons. The data are consistent with previous work and support clinical ketone intervention. The cognitive effects of ketogenic diets remain controversial, especially in healthy adults. To elucidate the effects of a ketogenic diet in healthy mice, C57BL6 mice were placed on a ketone-supplemented ketogenic diet for eight weeks. Recognition memory was assessed in a novel object recognition test and hippocampal bioenergetics were measured using high-resolution respirometry, western blot, and biochemical assays. The diet significantly improved recognition memory and enhanced hippocampal mitochondrial efficiency, measured by ATP production per unit of oxygen consumed, suggesting cognitive validity of the diet in middle-age. Long-term potentiation (LTP), the activity-dependent strengthening of synapses, within the hippocampus, is one of the molecular mechanisms of learning and memory formation. LTP of hippocampal Schaffer-collaterals was quantified in young adult C57BL/6 mice with field electrophysiology following ex vivo brain slice incubation with a β-hydroxybutyrate-rich ACSF. Mice were then placed on the ketone-supplemented diet for four weeks. Behavioral spatial memory was measured in the Morris water maze and Schaffer-collateral LTP was assessed with field electrophysiology. No meaningful changes in LTP and behavioral memory were observed with ketone treatment, suggesting ketogenic interventions may be more applicable in aging and pathologies that display cognitive deficits, rather than in healthy young adults. Together, these studies support the exploration of ketogenic interventions as a potential restorative measure in Alzheimer’s disease and preventative measure in aging, which may be impactful facing the rise of obesity and insulin resistance.